Financial Advisors, LLC Fulgent Genetics, Inc. Transaction History

Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$31.01 - $52.1 $465,150 - $781,500	-15,000 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$15.89 - $50.51 $63,560 - $202,040	-4,000 Reduced 21.05%	15,000 $601,000
Q1 2020 May 15, 2020	BUY	$6.75 - $19.75 $128,250 - $375,250	19,000 New	19,000 $204,000
Q1 2019 May 15, 2019	SELL	$3.47 - $6.05 $37,823 - $65,945	-10,900 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.12 - $4.09 $34,008 - $44,581	10,900 New	10,900 $35,000

199

14.7M

1.16M

92.9K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $594M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Financial Advisors, LLC with notifications on news.